Others

Alembic Pharmaceuticals Ltd. - Outcome of Board Meeting

| Updated on June 12, 2019 Published on June 12, 2019

With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter-alia (i) approved the Issue of Unsecured Listed Rated Redeemable Non-Convertible Debentures (NCDs) of upto Rs. 300 Crores on Private Placement Basis under a shelf disclosure document in one or more tranches and (ii) Constituted NCD Committee for issue and allotment of NCDs.

The time of commencement of the Board Meeting was 11:00 a.m. and the time of conclusion was 11:45 a.m.

Pdf Link: Alembic Pharmaceuticals Ltd. - Outcome of Board Meeting

Source : BSE - www.bseindia.com

Published on June 12, 2019
This article is closed for comments.
Please Email the Editor